ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

CrisprBits is developing CRISPR-based diagnostic tests that detect drug-resistant infections faster than traditional methods. The tests target specific genetic markers of antimicrobial resistance, enabling quicker treatment decisions for patients with bacterial infections.
Tap to vote and see what everyone thinks.
Summary by ByteBrief